Top

Published in:

01-08-2019 | Schizophrenia | Brief Report

Recovery-Oriented Outcomes Associated with Long-Acting Injectable Antipsychotics in an Urban Safety-Net Population

Authors: Kei Yoshimatsu, Andrea Elser, Melanie Thomas, James Dilley, Deborah Barnes, Alexandra Ballinger, Steven Wozniak, Christina Mangurian

Published in: Community Mental Health Journal | Issue 6/2019

Abstract

This study examined whether transitioning patients from oral antipsychotics (POs) to long-acting injectable antipsychotics (LAIs) helps patients achieve recovery-oriented goals. Data was extracted from San Francisco County’s electronic medical record system for this retrospective pre-post observational study. Patients reflect a safety-net population treated in community-based mental health settings during 2015. The San Francisco Adult Strengths and Needs Assessment (SF ANSA), a measure of psychosocial functioning, was used to assess within-subject change when treated with POs versus LAIs. In our study sample (N = 77), LAI SF ANSA scores showed significant improvements in criminal behaviors (p = .017), medication adherence (p = .008), and spirituality (p = .028), and a non-significant trend for residential stability (p = .073). This is the first study to evaluate improvements in key psychosocial areas after treatment with LAIs. This work suggests that LAIs can be another tool for providers to help patients work towards their recovery-oriented goals.

Cohen, A. N., Hamilton, A. B., Saks, E. R., Glover, D. L., Glynn, S. M., Brekke, J. S., et al. (2016). How occupationally high-achieving individuals with a diagnosis of schizophrenia manage their symptoms. Psychiatric Services, 68(4), 324–329. https://doi.org/10.1176/appi.ps.201600031.CrossRefPubMed

Community Behavioral Health Services. (2010). ANSA Ratings: Adult/Older Adult Assessment. City and County of San Francisco Department of Public Health. Retrieved from https://www.sfdph.org/dph/comupg/oservices/mentalHlth/CBHS/default.asp.

Gulcur, L., Stefancic, A., Shinn, M., Tsemberis, S., & Fischer Sean, N. (2003). Housing, hospitalization, and cost outcomes for homeless individuals with psychiatric disabilities participating in continuum of care and housing first programmes. Journal of Community & Applied Social Psychology, 13(2), 171–186. https://doi.org/10.1002/casp.723.CrossRef

Kane, J. M., Kishimoto, T., & Correll, C. U. (2013). Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry. Journal of Clinical Epidemiology, 66, 37–41.CrossRef

Kaplan, G., Casoy, J., & Zummo, J. (2013). Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia. Patient Preference and Adherence, 7, 1171–1180. https://doi.org/10.2147/PPA.S53795.CrossRefPubMedPubMedCentral

Lindenmayer, J. P., Liu-Seifert, H., Kulkarni, P. M., Kinon, B. J., Stauffer, V., Edwards, S. E., et al. (2009). Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response. Journal of Clinical Psychiatry, 70(7), 990–996. https://doi.org/10.4088/JCP.08m04221.CrossRefPubMed

Lynn Starr, H., Bermak, J., Mao, L., Rodriguez, S., & Alphs, L. (2017). Comparison of long-acting and oral antipsychotic treatment effects in patients with schizophrenia, comorbid substance abuse, and a history of recent incarceration: An exploratory analysis of the PRIDE study. Schizophrenia Research. https://doi.org/10.1016/j.schres.2017.05.005.CrossRefPubMed

Lyons, J. S., & Anderson, R. L. (1999). San Francisco Adult Needs and Strengths Assessment SF ANSA Manual: An Information Integration Tool for Adults with Behavioral Health Challenges. Retrieved from https://praedfoundation.org/tools/the-adult-needs-and-strengths-assessment-SFANSA/SFANSA-california/.

Marcus, S. C., Zummo, J., Pettit, A. R., Stoddard, J., & Doshi, J. A. (2015). Antipsychotic adherence and rehospitalization in schizophrenia patients receiving oral versus long-acting injectable antipsychotics following hospital discharge. Journal of Managed Care & Specialty Pharmacy, 21(9), 754–769. https://doi.org/10.18553/jmcp.2015.21.9.754.CrossRef

Miyamoto, S., & Wolfgang Fleischhacker, W. (2017). The use of long-acting injectable antipsychotics in schizophrenia. Current Treatment Options in Psychiatry, 4(2), 117–126. https://doi.org/10.1007/s40501-017-0115-z.CrossRefPubMedPubMedCentral

Olson, B., & Allen, R. S. (2015). Validity of the adult needs and strengths assessment with substance abuse populations. Journal of Addiction Research & Therapy, 06(03), 235. https://doi.org/10.4172/2155-6105.1000235.CrossRef

Rezansoff, S. N., Moniruzzaman, A., Fazel, S., Procyshyn, R., & Somers, J. M. (2016). Adherence to antipsychotic medication among homeless adults in Vancouver, Canada: A 15-year retrospective cohort study. Social Psychiatry and Psychiatric Epidemiology, 51(12), 1623–1632. https://doi.org/10.1007/s00127-016-1259-7.CrossRefPubMedPubMedCentral

Rosenheck, R. A., Krystal, J. H., Lew, R., Barnett, P. G., Fiore, L., Valley, D., et al. (2011). Long-acting risperidone and oral antipsychotics in unstable Schizophrenia. New England Journal of Medicine, 364(9), 842–851. https://doi.org/10.1056/NEJMoa1005987.CrossRefPubMed

Sajatovic, M., Ramirez, L. F., Fuentes-Casiano, E., Cage, J., Tatsuoka, C., Aebi, M. E., et al. (2017). A 6-month prospective trial of a personalized behavioral intervention + long-acting injectable antipsychotic in individuals with schizophrenia at risk of treatment nonadherence and homelessness. Journal of Clinical Psychopharmacology, 37(6), 702–707. https://doi.org/10.1097/JCP.0000000000000778.CrossRefPubMedPubMedCentral

Thomas, E. C., Despeaux, K. E., Drapalski, A. L., & Bennett, M. (2017). Person-oriented recovery of individuals with serious mental illnesses: A review and meta-analysis of longitudinal findings. Psychiatric Services, 1, 1. https://doi.org/10.1176/appi.ps.201700058.CrossRef

Title: Recovery-Oriented Outcomes Associated with Long-Acting Injectable Antipsychotics in an Urban Safety-Net Population
Authors: Kei Yoshimatsu
Andrea Elser
Melanie Thomas
James Dilley
Deborah Barnes
Alexandra Ballinger
Steven Wozniak
Christina Mangurian
Publication date: 01-08-2019
Publisher: Springer US
Keywords: Schizophrenia
Antipsychotics
Antipsychotics
Published in: Community Mental Health Journal / Issue 6/2019
Print ISSN: 0010-3853
Electronic ISSN: 1573-2789
DOI: https://doi.org/10.1007/s10597-019-00412-w

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Recovery-Oriented Outcomes Associated with Long-Acting Injectable Antipsychotics in an Urban Safety-Net Population

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2019

Relationship of Breastfeeding Self-Efficacy with Self-Esteem and General Health in Breastfeeding Mothers Referred to Health Centers of Falavarjan City-Iran, 2015

Prevalence of Childhood Mental Disorders Among School Children of Kashmir Valley

Service-Related Barriers and Facilitators in an Early Childhood System of Care: Comparing the Perspectives of Parents and Providers

Use of Smartphones, Computers and Social Media Among People with SMI: Opportunity for Intervention

Relationship Between Marital Quality, Social Support and Mental Health During Pregnancy

Consumers’ Suggestions for Improving the Mental Healthcare System: Options, Autonomy, and Respect